Search - tctmd.com

Displaying 81 - 100 of 129

Sort: Relevancy | Date

Presentation TCT 2013

Case #2 - PCI in a Patient with 3 Vessel Disease: Is the Syntax 2 Score Helpful in Decision-Making?

Presenter: Milan Nedeljkovic

October 31, 2013

Presentation TCT 2013

The SYNTAX Score Predicts Acute Kidney Injury After PCI for NSTEACS: Analysis from the ACUITY Trial

Presenter: Mahesh V. Madhavan

October 29, 2013

Presentation TCT 2013

TCT-21. Prognosis of Clinical Outcomes in Chinese Patients Receiving XIENCE V Everolimus-Eluting Stent with Baseline and Residual Syntax Score: One-Year Results from the...

Presenter: Yuejin Yang

October 29, 2013

Presentation TCT 2013

Case Presentation Introduction: A Patient with 3VD, Low/Intermediate SYNTAX Score, Moderate Symptoms and Moderate Ischemia by SPECT-MPS

Presenter: Michael Kutcher

October 29, 2013

Presentation TCT 2013

Case Presentation Introduction: A Patient with 3VD, Intermediate/High SYNTAX Score, Type II Diabetes, Moderate Co-Morbidiites adn Moderate Symptoms

Presenter: Antonio Colombo

October 29, 2013

Presentation TCT 2013

Yes! With Current DES and Pharmacotherapy, SYNTAX Is Already Obsolete and the Majority of Patients with MVD Can Be Managed with PCI

Presenter: Dean Kereiakes

October 28, 2013

Presentation TCT 2013

Yes! But the Biggest Change Is FFR: The Functional Syntax Score Should Guide Revascularization Decisions

Presenter: William Fearon

October 28, 2013

Presentation TCT 2013

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Presenter: David Cohen

October 28, 2013

Presentation TCT 2013

Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

Pros and Cons of SYNTAX Score II

Presenter: Davide Capodanno

October 28, 2013

Presentation TCT 2013

PCI vs CABG Rrisk-stratification: Is the SYNTAX Score II the Final Aarbiter...for Now?

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

Is the distal bifurcation an independent risk factor for adverse outcomes after left main PCI? SYNTAX 5-year results and other experiences

Presenter: Patrick Serruys

October 28, 2013

Presentation TCT 2013

Deep-dive Insights from the 5-year SYNTAX Left Main Results, and Relevance to 2013 Technology

Presenter: Marie-Claude Morice

October 28, 2013

Presentation TCT 2013

Risk Stratification in CAD: Insights From Freedom, Syntax and Beyond

Presenter: George Dangas

October 27, 2013

Presentation TCT 2013

Case Presentation: Multivessel Coronary Artery Disease - The Heart Team Approach, SYNTAX Score I and II, and FFR Guided Intervention

Presenter: Vasim Farooq

October 27, 2013

Presentation

SYNTAX: Short- and Long-term Clinical Impact of Stent Thrombosis and Graft Occlusion at 5 Years

Presenter: V. Farooq

October 21, 2013

Presentation SOLACI 2013

Ischemia Driven Revascularisation: Will FAME Overcome SYNTAX?

Presenter: Javier Escaned

July 25, 2013

Presentation TCT Russia 2013

MVD PCI: Lessons from Syntax & Freedom Trials?

Presenter: Bernard Chevalier

June 09, 2013

Presentation TCTAP 2013

The Fate of PCI for Multi-Vessel Disease From COURAGE to Syntax

Presenter: Seung-Jung Park

April 24, 2013

Presentation CTO 2013

Final SYNTAX Left Main Five-Year Results: Conclusions, Speculation, and Inferences

Presenter: Patrick Serruys

February 22, 2013

Advertisement

Case #2 - PCI in a Patient with 3 Vessel Disease: Is the Syntax 2 Score Helpful in Decision-Making?

The SYNTAX Score Predicts Acute Kidney Injury After PCI for NSTEACS: Analysis from the ACUITY Trial

TCT-21. Prognosis of Clinical Outcomes in Chinese Patients Receiving XIENCE V Everolimus-Eluting Stent with Baseline and Residual Syntax Score: One-Year Results from the...

Case Presentation Introduction: A Patient with 3VD, Low/Intermediate SYNTAX Score, Moderate Symptoms and Moderate Ischemia by SPECT-MPS

Case Presentation Introduction: A Patient with 3VD, Intermediate/High SYNTAX Score, Type II Diabetes, Moderate Co-Morbidiites adn Moderate Symptoms

Yes! With Current DES and Pharmacotherapy, SYNTAX Is Already Obsolete and the Majority of Patients with MVD Can Be Managed with PCI

Yes! But the Biggest Change Is FFR: The Functional Syntax Score Should Guide Revascularization Decisions

SYNTAX COST-EFFECTIVENESS: Final Five-Year Results from a Prospective, Randomized Trial of Paclitaxel-Eluting Stents vs. CABG in Patients with Triple Vessel and Left Main Corona...

Should the Presence of Diabetes Move Treatment Toward CABG Rather Than PCI? Historical Observations and Syntax Score II

Pros and Cons of SYNTAX Score II

PCI vs CABG Rrisk-stratification: Is the SYNTAX Score II the Final Aarbiter...for Now?

Is the distal bifurcation an independent risk factor for adverse outcomes after left main PCI? SYNTAX 5-year results and other experiences

Deep-dive Insights from the 5-year SYNTAX Left Main Results, and Relevance to 2013 Technology

Risk Stratification in CAD: Insights From Freedom, Syntax and Beyond

Case Presentation: Multivessel Coronary Artery Disease - The Heart Team Approach, SYNTAX Score I and II, and FFR Guided Intervention

SYNTAX: Short- and Long-term Clinical Impact of Stent Thrombosis and Graft Occlusion at 5 Years

Ischemia Driven Revascularisation: Will FAME Overcome SYNTAX?

MVD PCI: Lessons from Syntax & Freedom Trials?

The Fate of PCI for Multi-Vessel Disease From COURAGE to Syntax

Final SYNTAX Left Main Five-Year Results: Conclusions, Speculation, and Inferences

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content